SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare reports Profit after tax of Rs 168.79 Mln, in the December 2020 quarter

13 Feb 2021 Evaluate
The sales is pegged at Rs. 1713.00 millions for the December 2020 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 2169.29 millions during the year-ago period.A big decline of -70.53% was reported for the quarter ended December 2020 to Rs. 168.79  millions from Rs. 572.66 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 392.99 millions from 797.56 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202012 201912 % Var 202012 201912 % Var 202003 201903 % Var
Sales 1713.00 2169.29 -21.03 6506.14 6080.26 7.00 8059.71 6638.79 21.40
Other Income 86.06 24.30 254.16 187.62 82.92 126.27 112.63 155.33 -27.49
PBIDT 392.99 797.56 -50.73 2084.22 2039.08 2.21 2561.68 2040.79 25.52
Interest 39.47 10.95 260.46 108.27 30.42 255.92 43.29 27.94 54.94
PBDT 353.52 786.61 -55.06 2505.44 2008.66 24.73 2472.97 2075.10 19.17
Depreciation 104.80 86.18 21.61 302.29 257.99 17.17 349.57 340.14 2.77
PBT 248.72 700.43 -64.49 2203.15 1750.67 25.85 2123.40 1734.96 22.39
TAX 79.93 127.77 -37.44 625.16 329.95 89.47 441.46 377.46 16.96
Deferred Tax 34.71 0.44 7788.64 239.84 -7.67 -3226.99 50.52 -27.57 -283.24
PAT 168.79 572.66 -70.53 1577.99 1420.72 11.07 1681.94 1357.50 23.90
Equity 81.53 81.53 0.00 81.53 81.53 0.00 81.53 81.53 0.00
PBIDTM(%) 22.94 36.77 -37.60 32.03 33.54 -4.48 31.78 30.74 3.39

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×